Placenta-derived exosomes and syncytiotrophoblast microparticles and their role in human reproduction: immune modulation for pregnancy success
- PMID: 25164206
- DOI: 10.1111/aji.12311
Placenta-derived exosomes and syncytiotrophoblast microparticles and their role in human reproduction: immune modulation for pregnancy success
Abstract
The syncytiotrophoblast (STB) of human placenta constitutively produces and secretes extracellular vesicles of different size, morphology and function that enter the maternal circulation, and participate in the maternal-fetal cross-talk during pregnancy. Syncytiotrophoblast-derived microvesicles/microparticles (STBM) are larger microvesicles (0.2-2 μm) shed by the apical plasma membrane of the STB as a result of cell activation and turnover. Simultaneously with the STBM shedding, the STB produces and secretes exosomes--nanosized (30-100/150 nm) membrane-bound microvesicles that originate from the endosomal compartment. They convey cell-cell contact 'by proxy' transporting signals/packages of information between donor and recipient cells locally or/and at a distance. STBM and exosomes, delivered directly in the maternal blood surrounding the chorionic villi of the placenta, have contrasting biological functions. While the exosomes are immunosuppressive down regulating maternal immunity in pluripotent ways, the main effects of STBM on the maternal immune system are pro-inflammatory, immune activating, and pro-coagulant. Since both STBM and exosomes are present in the maternal circulation throughout normal pregnancy logical questions are what is the net effect of these vesicles on the maternal immune system and is this effect beneficial or detrimental to pregnancy. In this review, the current knowledge about placenta-derived extracellular vesicles with a main focus on exosomes is summarized and discussed. In a concluding remark, a hypothetical proposal on how STBM and exosomes might interact in pregnancy is discussed and a way to evaluate this interaction is suggested.
Keywords: STBM; exosomes; immunomodulation; microparticles/microvesicles; placenta; pregnancy.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Similar articles
-
The role of placental exosomes in reproduction.Am J Reprod Immunol. 2010 Jun;63(6):520-33. doi: 10.1111/j.1600-0897.2010.00822.x. Epub 2010 Mar 11. Am J Reprod Immunol. 2010. PMID: 20331583 Review.
-
Immunosuppressive Protein Signatures Carried by Syncytiotrophoblast-Derived Exosomes and Their Role in Human Pregnancy.Front Immunol. 2021 Jul 26;12:717884. doi: 10.3389/fimmu.2021.717884. eCollection 2021. Front Immunol. 2021. PMID: 34381459 Free PMC article. Review.
-
Feto-maternal interactions in pregnancies: placental microparticles activate peripheral blood monocytes.Placenta. 2010 Feb;31(2):106-12. doi: 10.1016/j.placenta.2009.11.011. Epub 2009 Dec 14. Placenta. 2010. PMID: 20005571
-
The functions of microparticles in pre-eclampsia.Semin Thromb Hemost. 2011 Mar;37(2):146-52. doi: 10.1055/s-0030-1270342. Epub 2011 Mar 2. Semin Thromb Hemost. 2011. PMID: 21370216 Review.
-
The immunomodulatory role of syncytiotrophoblast microvesicles.PLoS One. 2011;6(5):e20245. doi: 10.1371/journal.pone.0020245. Epub 2011 May 25. PLoS One. 2011. PMID: 21633494 Free PMC article.
Cited by
-
Placenta-targeted Treatment Strategies for Preeclampsia and Fetal Growth Restriction: An Opportunity and Major Challenge.Stem Cell Rev Rep. 2024 May 30. doi: 10.1007/s12015-024-10739-x. Online ahead of print. Stem Cell Rev Rep. 2024. PMID: 38814409 Review.
-
Targeting Neutrophil Extracellular Trap Formation: Exploring Promising Pharmacological Strategies for the Treatment of Preeclampsia.Pharmaceuticals (Basel). 2024 May 9;17(5):605. doi: 10.3390/ph17050605. Pharmaceuticals (Basel). 2024. PMID: 38794175 Free PMC article. Review.
-
Protective role of complement factor H against the development of preeclampsia.Front Immunol. 2024 Feb 23;15:1351898. doi: 10.3389/fimmu.2024.1351898. eCollection 2024. Front Immunol. 2024. PMID: 38464530 Free PMC article.
-
Lipid profile of circulating placental extracellular vesicles during pregnancy identifies foetal growth restriction risk.J Extracell Vesicles. 2024 Feb;13(2):e12413. doi: 10.1002/jev2.12413. J Extracell Vesicles. 2024. PMID: 38353485 Free PMC article.
-
Nuclear Binding Protein 2/Nesfatin-1 Affects Trophoblast Cell Fusion during Placental Development via the EGFR-PLCG1-CAMK4 Pathway.Int J Mol Sci. 2024 Feb 5;25(3):1925. doi: 10.3390/ijms25031925. Int J Mol Sci. 2024. PMID: 38339201 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical